IPO Year: 2023
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/5/2025 | $3.75 → $0.40 | Overweight → Neutral | Piper Sandler |
| 11/15/2024 | Neutral → Underperform | BofA Securities | |
| 10/14/2024 | Buy → Neutral | BofA Securities | |
| 8/16/2023 | Market Perform | SVB Securities | |
| 8/15/2023 | $20.00 | Overweight | Piper Sandler |
| 8/15/2023 | $18.00 | Buy | BofA Securities |
SCHEDULE 13G/A - Turnstone Biologics Corp. (0001764974) (Subject)
10-K - Turnstone Biologics Corp. (0001764974) (Filer)
8-K - Turnstone Biologics Corp. (0001764974) (Filer)
8-K - Turnstone Biologics Corp. (0001764974) (Filer)
10-Q - Turnstone Biologics Corp. (0001764974) (Filer)
8-K - Turnstone Biologics Corp. (0001764974) (Filer)
8-K - Turnstone Biologics Corp. (0001764974) (Filer)
8-K - Turnstone Biologics Corp. (0001764974) (Filer)
10-Q - Turnstone Biologics Corp. (0001764974) (Filer)
8-K - Turnstone Biologics Corp. (0001764974) (Filer)
Piper Sandler downgraded Turnstone Biologics from Overweight to Neutral and set a new price target of $0.40 from $3.75 previously
BofA Securities downgraded Turnstone Biologics from Neutral to Underperform
BofA Securities downgraded Turnstone Biologics from Buy to Neutral
SVB Securities initiated coverage of Turnstone Biologics with a rating of Market Perform
Piper Sandler initiated coverage of Turnstone Biologics with a rating of Overweight and set a new price target of $20.00
BofA Securities initiated coverage of Turnstone Biologics with a rating of Buy and set a new price target of $18.00
4 - Turnstone Biologics Corp. (0001764974) (Issuer)
4 - Turnstone Biologics Corp. (0001764974) (Issuer)
4 - Turnstone Biologics Corp. (0001764974) (Issuer)
4 - Turnstone Biologics Corp. (0001764974) (Issuer)
4 - Turnstone Biologics Corp. (0001764974) (Issuer)
4 - Turnstone Biologics Corp. (0001764974) (Issuer)
3 - Turnstone Biologics Corp. (0001764974) (Issuer)